ATE512158T1 - Differenziell geschützte, orthogonale lanthionintechnologie - Google Patents

Differenziell geschützte, orthogonale lanthionintechnologie

Info

Publication number
ATE512158T1
ATE512158T1 AT06789722T AT06789722T ATE512158T1 AT E512158 T1 ATE512158 T1 AT E512158T1 AT 06789722 T AT06789722 T AT 06789722T AT 06789722 T AT06789722 T AT 06789722T AT E512158 T1 ATE512158 T1 AT E512158T1
Authority
AT
Austria
Prior art keywords
provides
synthesizing
present
differentially protected
intramolecularly bridged
Prior art date
Application number
AT06789722T
Other languages
English (en)
Inventor
Jeffrey Hillman
Ravi Orugunty
James Smith
Original Assignee
Oragenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oragenics Inc filed Critical Oragenics Inc
Application granted granted Critical
Publication of ATE512158T1 publication Critical patent/ATE512158T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/062General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/063General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha-amino functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Materials For Medical Uses (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06789722T 2005-08-12 2006-08-11 Differenziell geschützte, orthogonale lanthionintechnologie ATE512158T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70808605P 2005-08-12 2005-08-12
US80890706P 2006-05-26 2006-05-26
PCT/US2006/031510 WO2007022012A2 (en) 2005-08-12 2006-08-11 Differentially protected orthogonal lanthionine technology

Publications (1)

Publication Number Publication Date
ATE512158T1 true ATE512158T1 (de) 2011-06-15

Family

ID=37460062

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06789722T ATE512158T1 (de) 2005-08-12 2006-08-11 Differenziell geschützte, orthogonale lanthionintechnologie

Country Status (9)

Country Link
US (1) US7521529B2 (de)
EP (1) EP1915389B1 (de)
JP (1) JP4955001B2 (de)
AT (1) ATE512158T1 (de)
AU (1) AU2006279749B2 (de)
CA (1) CA2618066A1 (de)
DK (1) DK1915389T3 (de)
NZ (1) NZ566546A (de)
WO (1) WO2007022012A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090215985A1 (en) * 2005-08-12 2009-08-27 Oragenics, Inc. Differentially protected orthogonal lanthionine technology
JP2010170886A (ja) * 2009-01-23 2010-08-05 Sony Corp 電解質および二次電池
WO2010091142A1 (en) * 2009-02-04 2010-08-12 President And Fellows Of Harvard College Compositions and methods for labeling and imaging phospholipids
EP2267003A1 (de) * 2009-06-24 2010-12-29 Applied NanoSystems B.V. Biologisch hergestellte cyclische Affinitätsmarker
HK1205458A1 (en) 2012-02-27 2015-12-18 Oragenics, Inc. Variants of the lantibiotic mu1140 and other lantibiotics with improved pharmacological properties and structural features
WO2014093196A1 (en) * 2012-12-10 2014-06-19 North Carolina State University Solid phase scaffold based libraries
CN103601640B (zh) * 2013-11-13 2015-07-29 迈克斯(如东)化工有限公司 一种环己烷三酮类化合物的制备方法
EP3122764B1 (de) * 2014-03-25 2019-01-16 LanthioPep B.V. Cyclische apelinanaloga
CN104478689A (zh) * 2015-01-09 2015-04-01 泰州施美康多肽药物技术有限公司 一种ivDde-OH的纯化方法
JP2019529344A (ja) 2016-07-15 2019-10-17 イントレキソン コーポレーション ランチビオティックバリアントおよびその使用
EP3612549A4 (de) * 2017-04-21 2021-05-26 Memorial Sloan-Kettering Cancer Center Lantibiotika, lantibiotikaproduzierende bakterien, zusammensetzungen und verfahren zur herstellung und verwendung davon

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256549A (en) * 1986-03-28 1993-10-26 Chiron Corporation Purification of synthetic oligomers
US5049656A (en) 1988-12-21 1991-09-17 Board Of Regents Of The University Of Nebraska Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques
US6028168A (en) * 1991-08-09 2000-02-22 Winfried Kolbeck Lanthionine bridged peptides
US5521184A (en) 1992-04-03 1996-05-28 Ciba-Geigy Corporation Pyrimidine derivatives and processes for the preparation thereof
US6794181B2 (en) * 2002-10-09 2004-09-21 Immucell Corporation Method of purifying lantibiotics
US7785825B2 (en) * 2004-01-12 2010-08-31 The Board Of Trustees Of The University Of Illinois Compositions and methods for dehydration and cyclization of peptides, synthetic compounds, and lantibiotics

Also Published As

Publication number Publication date
EP1915389B1 (de) 2011-06-08
EP1915389A2 (de) 2008-04-30
JP4955001B2 (ja) 2012-06-20
NZ566546A (en) 2011-01-28
AU2006279749A1 (en) 2007-02-22
AU2006279749B2 (en) 2012-12-20
US7521529B2 (en) 2009-04-21
US20070037963A1 (en) 2007-02-15
HK1112925A1 (en) 2008-09-19
JP2009505981A (ja) 2009-02-12
CA2618066A1 (en) 2007-02-22
WO2007022012A3 (en) 2007-08-30
DK1915389T3 (da) 2011-09-19
WO2007022012A2 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
DK1915389T3 (da) Differentielt beskyttet ortogonal lanthioninteknologi
MX2011009427A (es) Tecnologia de lantionina ortogonal diferencialmente protegida.
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
WO2004099231A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
IL267186B (en) Regulatory t-cell epitopes, their preparations and uses
CY1119106T1 (el) Αντισωματα εναντι masp-2
WO2003031464A3 (en) Remodeling and glycoconjugation of peptides
SG10201807877TA (en) Hybrid immunoglobulin containing non-peptidyl linkage
MXPA05003730A (es) Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina.
CY1114632T1 (el) Αντισωματα εναντι erbb3 και χρησεις εξ' αυτων
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
CL2004000016A1 (es) Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina.
CY1107254T1 (el) Μη πεπτιδικοι ανταγωνιστες της ωραδυκινινης και φαρμακευτικες συνθεσεις αυτων
DE69938935D1 (de) Zyklische conotoxin-peptide
EA200401455A1 (ru) Производные бензоксазина в качестве модуляторов 5-htи их применение
ATE484749T1 (de) Von anti-trichinella-antikörpern erkannte polypeptide und ihre verwendung
DK1344827T3 (da) Frostbeskyttende proteiner fra basidiomycetes
DE60207759D1 (de) Pyrimidotriazine als phosphataseinhibitoren
CY1105452T1 (el) Παραγωγα της κυκλοσπορινης και μεθοδος παρασκευης των εν λογω παραγωγων
NO20070775L (no) Baerer for medikamenter for oppnaelse av oral biotilgjengelighet
EA200601220A1 (ru) Анти-trkc антитела-агонисты и способы их применения
ATE489623T1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
ATE453663T1 (de) Zusammensetzungen von für pathogene stämme spezifischen polypeptiden und deren verwendung als impfstoffe und in der immuntherapie
BRPI0508916A (pt) polipeptìdeos hìbridos imunogênicos antiobesidade e composição de vacina antiobesidade compreendendo-os
MX2021006809A (es) Rutas lineales en fase de solucion para hexapeptidos de wnt.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties